Title: Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.
Journal: Psychopharmacology 20110801
Title: Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Journal: Behavioural brain research 20091105
Title: Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs.
Journal: Journal of medicinal chemistry 20071018
Title: Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities.
Journal: Journal of medicinal chemistry 20070222
Title: SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101
Title: Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901
Title: SAR study of 1-aryl-4-(phenylarylmethyl)piperazines as ligands for both dopamine D2 and serotonin 5-HT1A receptors showing varying degrees of (Ant)agonism. Selection of a potential atypical antipsychotic.
Journal: Chemical & pharmaceutical bulletin 20060901
Title: Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Journal: European journal of pharmacology 20060327
Title: Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.
Journal: European journal of pharmacology 20060318
Title: Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
Journal: Neuropharmacology 20050801
Title: Andrew C McCreary, et al. SLV313 (1-(2,3-dihydro-benzo,4dioxin-5-yl)-4- -(4-fluoro-phenyl)-pyridin-3-ylmethyl-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug. Neuropsychopharmacology. 2007 Jan;32(1):78-94.
Title: Liesbeth A Bruins Slot, et al. Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase. Eur J Pharmacol. 2006 Mar 18;534(1-3):63-70.
